Herman Krapf
Algemeen Directeur bij Eribis Pharmaceuticals AB
Profiel
Herman Krapf is the founder and Chief Executive Officer of Eribis Pharmaceuticals AB, a company founded in 2006.
He also held former positions as Manager-Marketing, Sales & Business Development at International Business Machines Corp., Pharmacia Biotech AB, and Helax AB.
Additionally, he served as Principal at LipoCore AB.
Actieve functies van Herman Krapf
| Bedrijven | Functie | Begin |
|---|---|---|
Eribis Pharmaceuticals AB
 Eribis Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Eribis Pharmaceuticals AB, ('Eribis') was founded by Erik Bissessar and co-founded by Herman Krapf. Karolinska Development is the primary investing partner. The basis of Eribis is the Company's unique competence in developing peptides for the pharmacological use for treatment of several clinical indications. The company's main focus is on developing new, effective and safe drugs for the treatment of cardiovascular disorders, in particular acute myocardial ischemia, and also for surgical preconditioning. The Company is based on research in the fields of peptide chemistry and pharmacology. The main goal for Eribis is to develop its Candidate Drug to meet the market's demand for new and improved treatment in the field of cardio-protection. Other medical indications may be considered at a later stage. | Algemeen Directeur | 01-01-2006 |
Eerdere bekende functies van Herman Krapf
| Bedrijven | Functie | Einde |
|---|---|---|
| LipoCore AB | Corporate Officer/Principal | - |
Helax AB
 Helax AB Medical SpecialtiesHealth Technology Part of Sotera Health Co., Helax AB is a Swedish company that provides products for radiation-based cancer treatment. The company is based in Uppsala, Sweden. The company was founded by Hans Erik Dahlin. Helax was acquired by Nordion (Canada), Inc., part of Sotera Health Co. from July 30, 2018 on May 04, 1999. | Verkoop & Marketing | - |
| IBM | Verkoop & Marketing | - |
| Pharmacia Biotech AB | Verkoop & Marketing | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| IBM | Technology Services |
| Bedrijven in privébezit | 4 |
|---|---|
Eribis Pharmaceuticals AB
Eribis Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Eribis Pharmaceuticals AB, ('Eribis') was founded by Erik Bissessar and co-founded by Herman Krapf. Karolinska Development is the primary investing partner. The basis of Eribis is the Company's unique competence in developing peptides for the pharmacological use for treatment of several clinical indications. The company's main focus is on developing new, effective and safe drugs for the treatment of cardiovascular disorders, in particular acute myocardial ischemia, and also for surgical preconditioning. The Company is based on research in the fields of peptide chemistry and pharmacology. The main goal for Eribis is to develop its Candidate Drug to meet the market's demand for new and improved treatment in the field of cardio-protection. Other medical indications may be considered at a later stage. | Health Technology |
| Pharmacia Biotech AB | Health Technology |
Helax AB
Helax AB Medical SpecialtiesHealth Technology Part of Sotera Health Co., Helax AB is a Swedish company that provides products for radiation-based cancer treatment. The company is based in Uppsala, Sweden. The company was founded by Hans Erik Dahlin. Helax was acquired by Nordion (Canada), Inc., part of Sotera Health Co. from July 30, 2018 on May 04, 1999. | Health Technology |
| LipoCore AB |
